Document Detail


Diastolic function parameters are improved by the addition of simvastatin to enalapril-based treatment in hypertensive individuals.
MedLine Citation:
PMID:  22554359     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
OBJECTIVE: Diastolic dysfunction (DD) is a frequent condition in hypertensive patients whose presence increases mortality and whose treatment remains unclear. The aim of this study was to investigate in a prospective, double-blinded, placebo-controlled randomized design the additive effect of simvastatin on DD in enalapril-treated hypertensive patients with average cholesterol levels. METHODS: Hypertensive patients with DD and LDL-cholesterol <160mg/dL underwent a run-in phase to achieve a systolic blood pressure (SBP) <135mmHg and diastolic blood pressure (DBP) <85mmHg with enalapril. Hydrochlorothiazide was added when need to achieve blood pressure control. Four weeks after reaching the optimum anti-hypertensive regimen patients were randomized to receive 80mg simvastatin (n=27) or placebo (n=28) for a period of 20 weeks. Echocardiograms were performed before and after treatment with measurement of maximum left atrial volume (LAV), conventional and tissue Doppler velocities in early diastole (E, e') and late diastole (A, a'). RESULTS: After 20 weeks, the simvastatin group presented reduction in SBP (-4±2mmHg, p=0.02), increase in E/A ratio (1.0±0.05 to 1.2±0.06, p=0.03) and decrease of LAV indexed to body surface area (24.5±0.9 to 21.1±0.8ml/m(2), p=0.048), as compared with placebo arm. No change in systolic function and no correlation between the E/A ratio, LAV and changes in blood pressure or lipid profile were observed. CONCLUSIONS: The addition of simvastatin to enalapril in hypertensive patients with average cholesterol levels improves parameters of diastolic function independently of changes in blood pressure or cholesterol.
Authors:
Adenalva L S Beck; Maria E B Otto; Luciana B O D Avila; Fernando M Netto; Marinez K Armendaris; Andrei C Sposito
Related Documents :
8221789 - Muscarinic receptor stimulation by carbachol improves functional recovery in isolated, ...
10094849 - Cardioprotective effect of enantiomers of cicletanine (bn50417, bn50418) in ischaemic/r...
9011639 - Myocardial glycogen depletion cannot explain the cardioprotective effects of ischemic p...
12145559 - Comparison of pulsatile and nonpulsatile perfusion of the lung in an extracorporeal lar...
1138399 - The mechanism of myocardial damage following potassium citrate (melrose) cardioplegia.
22451309 - Antemortem pulse pressure elevation predicts cerebrovascular disease in autopsy-confirm...
2005719 - Creation of a feline model of obstructive uropathy.
23183279 - Cardiovascular disease in an adenine-induced model of chronic kidney disease: the tempo...
7922189 - Autocrine-paracrine factors and vascular remodeling in hypertension.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-4-3
Journal Detail:
Title:  Atherosclerosis     Volume:  -     ISSN:  1879-1484     ISO Abbreviation:  -     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-5-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0242543     Medline TA:  Atherosclerosis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.
Affiliation:
Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil; Instituto de Cardiologia do Distrito Federal, Brasilia, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Detection of Nucleosomal Substructures using Solid State Nanopores.
Next Document:  The influence of language deprivation in early childhood on L2 processing: An ERP comparison of deaf...